New Hope For Breast Cancer Patients.New Hope For Breast Cancer Patients
Major Independent Trial Demonstrates Anticancer Benefit of Zometa (Zoledronic Acid) in Women With Early Stage Breast Cancer;
When added to hormone therapy, following surgery, Zometa significantly reduced the risk of cancer returning or death by 36% beyond clinical benefits achieved with hormone therapy alone;
Findings May Allow UAE (Uninterruptible Application Error) The name given to a crash in Windows 3.0. In subsequent versions of Windows, a crash was called a "General Protection Fault," "Application Error" or "Illegal Operation." See crash in Windows and abend. Doctors to Improve Standard of Care
A new independent trial presented at the 44th Annual Meeting of the American Society of Clinical Oncology American Society of Clinical Oncology, or ASCO, is an organization that represents all clinical oncologists. Every year, ASCO holds a large symposium where physicians and researchers meet to convey and discuss research and ideas. (ASCO ASCO American Society of Clinical Oncology
ASCO Association of Schools and Colleges of Optometry (since 1941; Rockville, Maryland)
ASCO Australian Standard Classification of Occupations
ASCO Automatic Switch Company ) showed that Zometa[R] offered a significant anticancer benefit for premenopausal pre·me·no·paus·al
Of or relating to the years or the stage of life immediately before the onset of menopause.
premenopausal adjective women with hormone-sensitive, early-stage breast cancer.
The study found that Zometa[R] when added to hormone therapy, following surgery, significantly reduced the risk of cancer returning or death by 36 percent beyond clinical benefits achieved with hormone therapy alone.
Zometa[R] is the treatment for prevention or delay of skeletal related events in patients with advanced bone tumors, slows the bone-destroying effect that occurs with bone metastases by fighting abnormal activation of the cells that normally break down old bone, and the cells that normally build new bone.
Zometa[R] has been shown to make passage through the stages of tumor growth more difficult by inhibiting angiogenesis angiogenesis /an·gio·gen·e·sis/ (-jen´e-sis) vasculogenesis; development of blood vessels either in the embryo or in the form of neovascularization or revascularization.
n. (formation of blood vessels that grow and feed cancer cells), stimulating cancer-fighting T-cells, inducing tumor cell apoptosis (programmed cell death pro·grammed cell death
programmed cell death
proposed system of cell death, often including poly(ADP)-ribosylation, ensures that a cell will not survive if it is so badly damaged that its recovery would harm the ) and increasing the activity of anticancer agents that target tumor cell metastases Metastasis (plural, metastases)
A tumor growth or deposit that has spread via lymph or blood to an area of the body remote from the primary tumor.
Mentioned in: Malignant Melanoma .
"Early detection of breast cancer in conjunction with advanced treatments available today give women a significantly better chance of survival," said Dr. Farid Khalifa, Consultant Oncologist and Head of Oncology Department, Dubai Health Authority.
This study is the first large-scale trial to demonstrate the significant antitumor an·ti·tu·mor also an·ti·tu·mor·al
Counteracting or preventing the formation of malignant tumors; anticancer.
Adj. 1. benefit of Zometa[R] and the findings may allow oncologists to further improve the standard of care for premenopausal women with hormone-sensitive early stage breast cancer.
Dr. Farid Khalifa, Consultant Oncologist and Head of Oncology Department, Dubai Health Authority, Dr. Falah Al Khatib, Gulf Cancer Center - UAE, and Dr. Salah Fayaz, consultant clinical oncologist and head of breast unit in Kuwait Cancer Center, attended ASCO which encourages worldwide collaboration on the latest cancer research and development of new cancer treatments.
[c] 2008 Al Bawaba (www.albawaba.com)